CRTAM-CADM1 INTERACTION IN THE BIOLOGY OF GUT LYMPHOCYTES

肠道淋巴细胞生物学中的 CRTAM-CADM1 相互作用

基本信息

  • 批准号:
    9253389
  • 负责人:
  • 金额:
    $ 34.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-03-01 至 2019-02-28
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): An inappropriate immune response towards microbial flora in genetically predisposed individuals results in inflammatory bowel disease (IBD). The pathogenic response in IBD is driven by CD4+TH17. Immunoregulatory mechanisms that prevent or counter IBD typically rely on Tregs and IL-10. However, recent studies have identified the involvement of intraepithelial CD4+CD8+T cells in the regulation of intestinal inflammation. Here, we have identified a novel molecular interaction between CRTAM on intestinal T cells and CADM1 on intestinal DC and demonstrated that this interaction is required for intraepithelial CD4+CD8+T cells in the steady-state and for TH17 responses during T. gondii parasitic infection. These results mandate further investigation of the impact of CRTAM-CADM1 interactions on intestinal immunity and their potential exploitation for IBD therapy. In Aim 1, we propose experiments to distinguish whether CRTAM-CADM1 interactions act: a) exclusively in the gut mucosa to facilitate the retention of CD4+T cells and CD4+CD8+ T cells, or b) in the mesenteric lymph nodes to promote priming of CD4+T cells and the acquisition of gut homing molecules. Aim 2 is based on the observation that CD4+CD8+ T cells are absent in germ-free mice, whereas short chain fatty acids (SCFA) induce their expansion. Thus, we will investigate the mechanisms by which the microbiota induces the differentiation of CD4+CD8+T cells and ask whether these mechanisms involve CRTAM-CADM1 interaction. CD4+CD8+T cells may require presentation of commensal antigens by intestinal CADM1+DCs. Alternatively, commensal microbiota may release metabolites that facilitate CD4+CD8+T cell differentiation, possibly by acting as histone deacetylase (HDAC) inhibitors that impact the epigenetics of CD4+CD8+T cell progenitors or CADM1+DCs. In Aim 3, we will explore the mechanisms for the CRTAM-CADM1 dependency of TH17 responses to T. gondii: we will determine whether TH17 cells detected during T. gondii infection are directed toward translocated commensals or are specific for T. gondii and whether CRTAM-CADM1 interactions impact TH17 response to commensals in general. Given the emerging importance of CD4+CD8+T cells in the regulation of intestinal immunity, the relevance of TH17 responses to autoimmunity and the need to manipulate these cells for therapy, this proposal to study CRTAM-CADM1 interactions embodies a new perspective in intestinal immunity that is highly innovative and relevant to IBD.
 描述(由申请方提供):遗传易感个体对微生物植物群的不适当免疫应答导致炎症性肠病(IBD)。IBD中的致病反应由CD 4 + TH 17驱动。预防或对抗IBD的免疫调节机制通常依赖于TdR和IL-10。然而,最近的研究已经确定了上皮内CD 4 + CD 8 +T细胞参与肠道炎症的调节。在这里,我们已经确定了肠T细胞上的CRTAM和肠DC上的CADM 1之间的新的分子相互作用,并证明了这种相互作用是稳态上皮内CD 4 + CD 8 +T细胞和T细胞增殖过程中TH 17应答所必需的。弓形虫感染这些结果要求进一步研究CRTAM-CADM 1相互作用对肠道免疫的影响及其对IBD治疗的潜在利用。在目的1中,我们提出了区分CRTAM-CADM 1相互作用是否:a)仅在肠粘膜中起作用以促进CD 4 +T细胞和CD 4 + CD 8 + T细胞的保留,或B)在肠系膜淋巴结中起作用以促进CD 4 +T细胞的引发和肠归巢分子的获得。目的2是基于无菌小鼠中不存在CD 4 + CD 8 + T细胞,而短链脂肪酸(SCFA)诱导其扩增的观察。因此,我们将研究微生物群诱导CD 4 + CD 8 +T细胞分化的机制,并询问这些机制是否涉及CRTAM-CADM 1相互作用。CD 4 + CD 8 +T细胞可能需要肠道CADM 1 +DCs呈递抗原。或者,肠道微生物群可以释放促进CD 4 + CD 8 +T细胞分化的代谢物,可能通过充当影响CD 4 + CD 8 +T细胞祖细胞或CADM 1 + DC的表观遗传学的组蛋白脱乙酰酶(HDAC)抑制剂。在目的3中,我们将探索CRTAM-CADM 1依赖性TH 17对T.弓形虫:我们将确定T.弓形虫感染是针对易位的宿主或特异于弓形虫。以及CRTAM-CADM 1的相互作用是否影响TH 17对一般的弓形虫的反应。鉴于CD 4 + CD 8 +T细胞在肠道免疫调节中的重要性,TH 17对自身免疫的反应的相关性以及操纵这些细胞用于治疗的需要,研究CRTAM-CADM 1相互作用的建议体现了肠道免疫的新视角,这是高度创新的,与IBD相关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARCO COLONNA其他文献

MARCO COLONNA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARCO COLONNA', 18)}}的其他基金

Mucosal Immune Defense Mechanisms of the Urinary Bladder
膀胱粘膜免疫防御机制
  • 批准号:
    10587639
  • 财政年份:
    2023
  • 资助金额:
    $ 34.31万
  • 项目类别:
Soluble TREM2 regulation of microglial function in Alzheimer disease
可溶性 TREM2 对阿尔茨海默病小胶质细胞功能的调节
  • 批准号:
    10432584
  • 财政年份:
    2022
  • 资助金额:
    $ 34.31万
  • 项目类别:
Impact of polyamines on ILC3 function at steady state and in preclinical model of colitis
多胺对稳态和结肠炎临床前模型中 ILC3 功能的影响
  • 批准号:
    10528082
  • 财政年份:
    2022
  • 资助金额:
    $ 34.31万
  • 项目类别:
The protein tyrosine kinase SYK drives innate immune responses against Alzheimer's Disease
蛋白质酪氨酸激酶 SYK 驱动针对阿尔茨海默病的先天免疫反应
  • 批准号:
    10674689
  • 财政年份:
    2022
  • 资助金额:
    $ 34.31万
  • 项目类别:
Impact of polyamines on ILC3 function at steady state and in preclinical model of colitis
多胺对稳态和结肠炎临床前模型中 ILC3 功能的影响
  • 批准号:
    10623342
  • 财政年份:
    2022
  • 资助金额:
    $ 34.31万
  • 项目类别:
Ontogenetic niche of B cells at the CNS borders in homeostasis, aging and autoimmunity
CNS 边界 B 细胞在稳态、衰老和自身免疫中的个体发育生态位
  • 批准号:
    10446266
  • 财政年份:
    2022
  • 资助金额:
    $ 34.31万
  • 项目类别:
Ontogenetic niche of B cells at the CNS borders in homeostasis, aging and autoimmunity
CNS 边界 B 细胞在稳态、衰老和自身免疫中的个体发育生态位
  • 批准号:
    10557870
  • 财政年份:
    2022
  • 资助金额:
    $ 34.31万
  • 项目类别:
Targeting TREM2 to boost anti-cancer therapy
靶向 TREM2 促进抗癌治疗
  • 批准号:
    10477296
  • 财政年份:
    2021
  • 资助金额:
    $ 34.31万
  • 项目类别:
MICROBIOTA-DEPENDENT CONTROL OF CLOSTRIDIUM DIFFICILE: THE ROLE OF ACETATE AND IL-22 BINDING PROTEIN
艰难梭菌的微生物群依赖性控制:乙酸盐和 IL-22 结合蛋白的作用
  • 批准号:
    10321553
  • 财政年份:
    2021
  • 资助金额:
    $ 34.31万
  • 项目类别:
Targeting TREM2 to boost anti-cancer therapy
靶向 TREM2 促进抗癌治疗
  • 批准号:
    10279674
  • 财政年份:
    2021
  • 资助金额:
    $ 34.31万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Autoimmunity to LINE-1-encoded antigens in SLE pathogenesis
SLE 发病机制中对 LINE-1 编码抗原的自身免疫
  • 批准号:
    9908850
  • 财政年份:
    2020
  • 资助金额:
    $ 34.31万
  • 项目类别:
Establishment of murine models of myositis depending on autoimmunity to dermatomyositis-specific antigens
基于皮肌炎特异性抗原自身免疫的小鼠肌炎模型的建立
  • 批准号:
    18K08263
  • 财政年份:
    2018
  • 资助金额:
    $ 34.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Autoimmunity Against Novel Antigens in Neuropsychiatric Dysfunction
神经精神功能障碍中针对新抗原的自身免疫
  • 批准号:
    8658474
  • 财政年份:
    2011
  • 资助金额:
    $ 34.31万
  • 项目类别:
Autoimmunity Against Novel Antigens in Neuropsychiatric Dysfunction
神经精神功能障碍中针对新抗原的自身免疫
  • 批准号:
    8179641
  • 财政年份:
    2011
  • 资助金额:
    $ 34.31万
  • 项目类别:
Autoimmunity Against Novel Antigens in Neuropsychiatric Dysfunction
神经精神功能障碍中针对新抗原的自身免疫
  • 批准号:
    8307781
  • 财政年份:
    2011
  • 资助金额:
    $ 34.31万
  • 项目类别:
Autoimmunity Against Novel Antigens in Neuropsychiatric Dysfunction
神经精神功能障碍中针对新抗原的自身免疫
  • 批准号:
    8525457
  • 财政年份:
    2011
  • 资助金额:
    $ 34.31万
  • 项目类别:
Autoimmunity caused by T cells recognizing tissue restricted antigens with low avidity
T 细胞识别低亲合力组织限制性抗原引起的自身免疫
  • 批准号:
    37945399
  • 财政年份:
    2007
  • 资助金额:
    $ 34.31万
  • 项目类别:
    Research Fellowships
Antigens of the RNA-induced silencing complex in autoimmunity
自身免疫中RNA诱导的沉默复合物的抗原
  • 批准号:
    7336803
  • 财政年份:
    2001
  • 资助金额:
    $ 34.31万
  • 项目类别:
Antigens of the RNA-induced silencing complex in autoimmunity
自身免疫中RNA诱导的沉默复合物的抗原
  • 批准号:
    7560044
  • 财政年份:
    2001
  • 资助金额:
    $ 34.31万
  • 项目类别:
Antigens of the RNA-induced silencing complex in autoimmunity
自身免疫中RNA诱导的沉默复合物的抗原
  • 批准号:
    7740863
  • 财政年份:
    2001
  • 资助金额:
    $ 34.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了